1 – 15 of 59
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Tru-Cut Biopsy in Gynecological Cancer: Adequacy, Accuracy, Safety and Clinical Applicability
(
- Contribution to journal › Article
-
Mark
Age and Referral Route Impact the Access to Diagnosis for Women with Advanced Ovarian Cancer
(
- Contribution to journal › Article
-
Mark
Imaging ovarian cancer - from baseline characteristics to high-risk image factors
(
- Contribution to journal › Article
- 2022
-
Mark
Prognostic Value of Peritoneal Cancer Index After Complete Cytoreductive Surgery in Advanced Ovarian Cancer
(
- Contribution to journal › Article
-
Mark
The role of computed tomography in the assessment of tumour extent and the risk of residual disease after upfront surgery in advanced ovarian cancer (AOC)
2022) In Archives of Gynecology and Obstetrics(
- Contribution to journal › Article
-
Mark
Ovarian tumor frozen section, a multidisciplinary affair
(
- Contribution to journal › Article
-
Mark
Copy number signatures for early diagnosis of high-grade serous ovarian carcinoma
2022) “FUTURE PERSPECTIVES IN OVARIAN CANCER RESEARCH”(
- Contribution to conference › Poster
- 2021
-
Mark
Outcomes Following Exenteration for Gynecological Neoplasms
2021) p.265-282(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
(
- Contribution to journal › Article
- 2020
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
(
- Contribution to journal › Article
-
Mark
Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters
(
- Contribution to journal › Article
-
Mark
High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer
(
- Contribution to journal › Article
-
Mark
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
(
- Contribution to journal › Article
- 2019
-
Mark
Albumin infusion rate and plasma volume expansion : A randomized clinical trial in postoperative patients after major surgery
(
- Contribution to journal › Article
-
Mark
Can we extend the indication for sentinel node biopsy in vulvar cancer? A nationwide feasibility study from Sweden
2019) In International Journal of Gynecological Cancer(
- Contribution to journal › Article